AGITG MONARCC: A Randomized Phase 2 Study of Panitumumab Monotherapy and Panitumumab Plus 5-Fluorouracil as First-Line Therapy for Older Patients With RAS and BRAF Wild Type Metastatic Colorectal Cancer. A Study by the Australasian Gastro-Intestinal Trials Group (AGITG).
Saved in:
| Title: | AGITG MONARCC: A Randomized Phase 2 Study of Panitumumab Monotherapy and Panitumumab Plus 5-Fluorouracil as First-Line Therapy for Older Patients With RAS and BRAF Wild Type Metastatic Colorectal Cancer. A Study by the Australasian Gastro-Intestinal Trials Group (AGITG). |
|---|---|
| Authors: | Burge ME; Royal Brisbane and Women's Hospital, Brisbane, Australia; The University of Queensland, Brisbane, Australia. Electronic address: Matthew.burge@health.qld.gov.au., Espinoza D; NHMRC Clinical Trials Centre, The University of Sydney, New South Wales, Australia., Sjoquist KM; NHMRC Clinical Trials Centre, The University of Sydney, New South Wales, Australia., Siu DH; NHMRC Clinical Trials Centre, The University of Sydney, New South Wales, Australia., Mercieca-Bebber R; NHMRC Clinical Trials Centre, The University of Sydney, New South Wales, Australia., Chantrill LA; Shoalhaven District Memorial Hospital, New South Wales, Australia., Karapetis CS; Flinders Medical Centre, Adelaide, South Australia; Flinders University, South Australia., Steer CB; Border Medical Oncology, Albury Wodonga Regional Cancer Centre, Victoria, Australia., Yip S; NHMRC Clinical Trials Centre, The University of Sydney, New South Wales, Australia., Cuff J; Australasian Gastro-Intestinal Trials Group-Community Advisory Panel. Level 6, Camperdown, New South Wales, Australia., Winata S; NHMRC Clinical Trials Centre, The University of Sydney, New South Wales, Australia., Tie J; Sunshine Hospital, Victoria, Australia., Thaker DA; Royal Brisbane and Women's Hospital, Brisbane, Australia., Srivastav R; The Tweed Hospital, Tweed Heads, New South Wales, Australia., Abdi E; The Tweed Hospital, Tweed Heads, New South Wales, Australia; Griffith University, Southport, Queensland, Australia., Strickland A; Department of Medical Oncology, Monash Health, Clayton, Victoria, Australia; Monash University, Clayton, Australia., Segelov E; Department of Medical Oncology, Monash Health, Clayton, Victoria, Australia., Francesconi A; Sunshine Coast University Hospital, Birtinya, Queensland, Australia., Price T; The Queen Elizabeth Hospital, Woodville South, South Australia., Ladwa R; Princess Alexandra Hospital, Woolloongabba, Queensland, Australia., Joubert W; Princess Alexandra Hospital, Woolloongabba, Queensland, Australia., Tebbutt NC; Austin Hospital, Heidelberg, Victoria, Australia. |
| Source: | Clinical colorectal cancer [Clin Colorectal Cancer] 2025 Jun; Vol. 24 (2), pp. 120-128. Date of Electronic Publication: 2024 Dec 12. |
| Publication Type: | Journal Article; Clinical Trial, Phase II; Randomized Controlled Trial; Multicenter Study; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 101120693 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0674 (Electronic) Linking ISSN: 15330028 NLM ISO Abbreviation: Clin Colorectal Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1938-0674 |
|---|---|
| DOI: | 10.1016/j.clcc.2024.11.003 |
